$250 grant.  Up to two awards will be given and will be announced at the
Division meeting during the AACC Annual Meeting.  To compete for this
award, you must:

• Submit an abstract in the field of therapeutic drug management
  or toxicology
• Be the presenting author of an accepted abstract for the
  upcoming AACC Annual Meeting

Abstract Winners

• 2012:
  Matt Petrie, D-149: UGT1A1*28 and UGT2B7*2 Polymorphisms do not Significantly Affect the Formation of Ethyl Glucuronide in vivo
  John Wilson, D-140: Analysis of Commercial "Bath Salts" Blends by GC/MS


• 2011:
  Mark Borgman, B-10: Prospective Validation of Plasma S-Warfarin Concentration-Time Profiles Adjusted for CYP2C9 Genotype
  Werner Steimer, B-43: Falsely Elevated Immunosuppressant Concentrations: Reversible Adsorption to a Variety of Central Venous Catheters


• 2010:
  Lindsay Hardy, E-70: Ethylene Glycol Screening: Adapting the CATACHEM Enzymatic Assay to Minimize False Positives
  Roy Gerona, E-120: Clinical Utility of an LC-MS/TOF Seizure Panel in Emergency Department's Seizure Patients